Zhu D, Hu J, Tan R, Lin X, Wang R, Lu J
Nat Prod Bioprospect. 2025; 15(1):16.
PMID: 40042546
PMC: 11882491.
DOI: 10.1007/s13659-025-00500-3.
Ivanov S, Lagunin A, Tarasova O
Comput Struct Biotechnol J. 2025; 23:3559-3574.
PMID: 39963421
PMC: 11832006.
DOI: 10.1016/j.csbj.2024.09.022.
Halu A, Chelvanambi S, Decano J, Matamalas J, Whelan M, Asano T
Genome Med. 2025; 17(1):7.
PMID: 39833831
PMC: 11744892.
DOI: 10.1186/s13073-025-01431-x.
Guo Y, Dai Y, Yin J, Song Y, Wang T, Zhang L
Am J Cancer Res. 2024; 14(9):4411-4428.
PMID: 39417183
PMC: 11477819.
DOI: 10.62347/TIMD7591.
Khan R, Tiwari S, Jarkharya A, Tiwari A, Chowdhary R, Shrivastava A
Microrna. 2024; 13(3):240-250.
PMID: 38982916
DOI: 10.2174/0122115366302365240618122812.
Identification of Differentially Expressed mRNAs and lncRNAs Contributes to Elucidation of Underlying Pathogenesis and Therapeutic Strategy of Recurrent Implantation Failure.
Liu L, Liu Y, Tian Y, Cao Y, Wang T, Mi S
Reprod Sci. 2024; .
PMID: 38955937
DOI: 10.1007/s43032-024-01630-8.
Melasolv™: a potential preventive and depigmenting agent for the senescence of melanocytes.
Cho Y, Choi S, Choi H, Ham M, Kim K
Front Mol Biosci. 2024; 10:1228640.
PMID: 38482540
PMC: 10935553.
DOI: 10.3389/fmolb.2023.1228640.
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease.
Anderson C, Bucholc M, McClean P, Zhang S
Biomolecules. 2024; 14(1).
PMID: 38275752
PMC: 10813465.
DOI: 10.3390/biom14010011.
Pharmacogenomic Analysis of Combined Therapies against Glioblastoma Based on Cell Markers from Single-Cell Sequencing.
Liu J, Wu R, Yuan S, Kelleher R, Chen S, Chen R
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004399
PMC: 10675611.
DOI: 10.3390/ph16111533.
Repurposing thioridazine for inducing immunogenic cell death in colorectal cancer via eIF2α/ATF4/CHOP and secretory autophagy pathways.
Tran T, Kao M, Liu H, Hong Y, Su Y, Huang C
Cell Commun Signal. 2023; 21(1):184.
PMID: 37488534
PMC: 10364410.
DOI: 10.1186/s12964-023-01190-5.
Cinchonine, a Potential Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist, Lowers Blood Glucose and Ameliorates Non-Alcoholic Steatohepatitis.
Xue H, Xing H, Wang B, Fu C, Zhang Y, Qiao X
Drug Des Devel Ther. 2023; 17:1417-1432.
PMID: 37197367
PMC: 10184894.
DOI: 10.2147/DDDT.S404055.
A Cocktail of Natural Compounds Holds Promise for New Immunotherapeutic Potential in Head and Neck Cancer.
Kumar S, Das A
Chin J Integr Med. 2023; 30(1):42-51.
PMID: 37118529
DOI: 10.1007/s11655-023-3694-0.
Identification of significant gene expression changes in multiple perturbation experiments using knockoffs.
Zhao T, Zhu G, Dubey H, Flaherty P
Brief Bioinform. 2023; 24(2).
PMID: 36892174
PMC: 10025447.
DOI: 10.1093/bib/bbad084.
Specific gene module pair-based target identification and drug discovery.
Li P, Bai C, Zhan L, Zhang H, Zhang Y, Zhang W
Front Pharmacol. 2023; 13:1089217.
PMID: 36726786
PMC: 9886283.
DOI: 10.3389/fphar.2022.1089217.
Identification of potential pathways and biomarkers linked to progression in ALS.
Huber R, Pandey S, Chhangani D, Rincon-Limas D, Staff N, Yeo C
Ann Clin Transl Neurol. 2022; 10(2):150-165.
PMID: 36533811
PMC: 9930436.
DOI: 10.1002/acn3.51697.
Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer.
Huang S, Hu P, Lakowski T
Pharmacogenomics J. 2022; 23(4):61-72.
PMID: 36424525
PMC: 10382320.
DOI: 10.1038/s41397-022-00297-1.
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities.
Shah I, Bundy J, Chambers B, Everett L, Haggard D, Harrill J
Chem Res Toxicol. 2022; 35(11):1929-1949.
PMID: 36301716
PMC: 10483698.
DOI: 10.1021/acs.chemrestox.2c00245.
DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery.
Wei Z, Zhu S, Chen X, Zhu C, Duan B, Liu Q
Genomics Proteomics Bioinformatics. 2022; 20(5):1028-1036.
PMID: 36182102
PMC: 10025590.
DOI: 10.1016/j.gpb.2022.09.006.
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants.
Xing J, Shankar R, Ko M, Zhang K, Zhang S, Drelich A
iScience. 2022; 25(10):105068.
PMID: 36093376
PMC: 9439871.
DOI: 10.1016/j.isci.2022.105068.
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma.
Li Q, Demir S, Del Rio-Alvarez A, Maxwell R, Wagner A, Carrillo-Reixach J
Cancers (Basel). 2022; 14(17).
PMID: 36077733
PMC: 9454988.
DOI: 10.3390/cancers14174196.